jamisonkimbrou

User Cover

jamisonkimbrou

@jamisonkimbrou

Following

Instant Instagram Post Viewer Tool: See Any Post P

Male
Social Links
Bio
Does low testosterone have a causative role in promoting worsening cardiovascular health or does it simply mark out a population of less healthy men, or both? The risk of death was greater for men in the lowest baseline quartile of both total and bioavailable testosterone compared with those in the highest quartile. More modern studies have been more consistent in design and definition, especially when the primary hypothesis was related to the question of the link between testosterone blood level and CAD. The metabolic syndrome is a well-recognized risk factor for atherosclerosis and coronary morbidity and mortality. Total testosterone fell at a rate of 0.11 nmol l−1 year−1, but the fall in free testosterone was more impressive and due, at least in part, to the significant rise of sex hormone binding globulin with age. Harman et al.25 investigated the nature and potential aetiological factors involved in the change in sex hormone levels with age in the Baltimore Longitudinal Study of Aging.
Testosterone does not appear to increase the risk of developing prostate cancer. Adult testosterone effects are more clearly demonstrable in males than in females, but are likely important to both sexes. Both testosterone and DHT bind to an androgen receptor; however, DHT has a stronger binding affinity than testosterone and may have more androgenic effect in certain tissues at lower levels. Since testosterone levels decrease as men age, testosterone is sometimes used in older men to counteract this deficiency. In addition to its role as a natural hormone, testosterone is used as a medication to treat hypogonadism and breast cancer. On average, in adult males, levels of testosterone are about seven to eight times as great as in adult females. The U.S. FDA recommends that all T supplements carry a warning that they may increase the risk of heart attack and stroke.
They must also decide whether to study men with normal testosterone levels or men who have low levels (called hypogonadism), either because of natural factors or because of androgen-deprivation therapy for prostate cancer. The TRAVERSE trial, a large‐scale, randomized, placebo‐controlled study, provided robust evidence that testosterone therapy does not significantly increase the risk of major adverse cardiovascular events. Although these trials are assessing outcomes in men with hypogonadism and prostate cancer, it is also important to study effects in older men who do not have these conditions, as they have an increased likelihood of using testosterone therapies. The Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) study is an ongoing clinical trial designed to measure the time to major adverse cardiovascular events in hypogonadal men, aged 45 to 80 years, with increased risk or evidence of CVD.36 The study commenced in May 2018 and is expected to be completed in June 2022, with 6000 planned participants randomized to receive topical testosterone or placebo.36 This clinical trial will play an important role in determining the safety of TRT in hypogonadal men. The indication of an association between testosterone therapy and risk for adverse cardiovascular events prompted the US Food and Drug Administration (FDA) to issue a safety warning on testosterone therapy for older men, which was followed by a reduction in testosterone prescriptions.30 The safety warning cautioned against the use of testosterone therapy for aging-related decline and reinforced the current approval of testosterone products for hypogonadal men only.30 However, it is important to note that the methodology and reliability of the aforementioned studies have since been questioned. Thus, although many studies have found inverse associations between endogenous testosterone levels and cardiovascular risk and mortality, conflicting results and heterogeneous study populations have prevented firm conclusions from being drawn.
Men who watch sexually explicit films also report increased motivation and competitiveness, and decreased exhaustion. Men who watch a sexually explicit movie have an average increase of 35% in testosterone, peaking at 60–90 minutes after the end of the film, but no increase is seen in men who watch sexually neutral films. In non-human primates, it may be that testosterone in puberty stimulates sexual arousal, which allows the primate to increasingly seek out sexual experiences with females and thus creates a sexual preference for females. Sexual arousal and masturbation in women produce small increases in testosterone concentrations. 2020 guidelines from the American College of Physicians support the discussion of testosterone treatment in adult men with age-related low levels of testosterone who have sexual dysfunction. It is unclear if the use of testosterone for low levels due to aging is beneficial or harmful.
Similar to the previous reports, TRT resulted in a significant increase in hemoglobin levels.36 However, none of the individual prostate-related adverse events significantly differed between groups, including incident prostate cancer, which showed no difference between the TRT group and placebo.34 In 2016, Boyle et al. reported results of a meta-analysis on prostate cancer in TRT trials. The TRT group had a significantly greater incidence of all prostate-related adverse events, with a pooled odds ratio of 1.78 (95% CI, 1.07–2.95). All four studies included in this meta-analysis evaluated the effects of TRT on LVEF as well. The authors also verified that the odds ratio for having hypogonadism was significantly higher in obese men, and there was a statistically significant negative correlation between total T level and BMI.15 Testosterone replacement therapy (TRT) has been shown to decrease fat mass. Whether low T and increased mortality are simply covariates or a causal relationship remains to be proven.
In measurements of testosterone in blood samples, different assay techniques can yield different results. Several professional medical groups have recommended that 350 ng/dL generally be considered the minimum normal level, which is consistent with previous findings.non-primary source neededmedical citation needed Levels of testosterone in men decline with age. Although commonly used as a reference range, some physicians have disputed the use of this range to determine hypogonadism. Two of the immediate metabolites of testosterone, 5α-DHT and estradiol, are biologically important and can be formed both in the liver and in extrahepatic tissues.
Other potential side effects include polycythemia (an excessive number of red blood cells), sleep apnea, gynecomastia (benign breast enlargement), acne, and liver disease. Until recently, men who needed testosterone required injections of the hormone every one to three weeks. Causes of testosterone deficiency include testicular failure due to genetic errors, mumps, severe trauma, alcoholism, and cancer chemotherapy and radiation. Testosterone therapy may be safe for the heart, but how about the rest of the body? After 12 weeks, testosterone produced a 33% increase in the distance the men were able to walk on a treadmill as well as a decrease in symptoms. In another 2004 trial, 20 men with heart failure were given testosterone injections or placebo. Men who undergo androgen-deprivation therapy develop abnormally stiff arteries.
Based on epidemiological studies, and the results of T4DM and TRAVERSE, additional studies are needed to confirm long-term cardiovascular safety, and explore possible cardiovascular benefits related to changes in body composition and cardiometabolic risk. This narrative review summarizes the relationships between testosterone and cardiovascular health outcomes, based on observational and interventional studies. Whether lower testosterone concentrations in aging men predispose to poorer health, particularly cardiovascular disease (CVD), remains controversial. Men considering TRT should discuss possible risks with their doctor, especially if they have any cardiovascular disease risk factors. For the others, it contained enough testosterone to maintain their hormone levels between 350 and 750 ng/dL. Researchers enrolled 5,246 men ages 45 to 80 with testosterone levels of less than 300 nanograms per deciliter (ng/dL). The findings from the TRAVERSE trial and supporting studies provide strong evidence that TTh does not significantly increase the risk of MACE.
The lowest quartile was also at higher risk for incident dyslipidemia, with a stronger effect noted in younger men (20–39 years age). They divided the men into quartiles of T levels and noted that the lowest quartile of men had higher total cholesterol and triglyceride levels in both cross-sectional and longitudinal analyses. In the Study of Health in Pomerania, Haring et al. examined the relationship between T levels and lipids, both at baseline and prospectively over 5 years. In parallel to these clinical investigations, ongoing research efforts have been invested in better understanding the mechanisms by which T may influence cardiovascular health. In this randomized trial, investigators have examined the effects of TRT in approximately 800 older, hypogonadal men over a 1-year treatment period. Overall, these types of retrospective analyses do not substantiate conclusions assigning a causal role for TRT in the development of cardiovascular morbidity but they clearly underscore the need for larger, randomized trials of TRT and CVD. In a second study, Finkle et al. used a large healthcare database and also reported an association between T prescriptions and myocardial infarction in older men in the immediate 90-day postprescription period .
https://dgwork.co.kr/abbyhartman86

Artists to Follow

Weekly Top Tracks

Ho leishabi

Delta

EKAI NUNGSHI YANARESONG

Delta

ningjaba mana

Delta

Mahayara Mayara

Delta

Yenglaga Penjarage

Delta

Nungshirure

Delta

Thamoi-Hubi-Leirangni-anew

Delta

Langlagi Jagoi

Delta

SONALI-MANIPURI-NUNGDI-NUNGSHI-O

Delta

HADA LOIYUMBA

Delta

Blogs • DMCA • About Us • Terms • Contact • Privacy Policy • Faqs

© 2026 Delta Songs

:: / ::

::

/ ::

Queue